U.S. Market for Soft Tissue Reinforcement and Regeneration 2015
The U.S. market for soft tissue reinforcement and regeneration includes medical graft devices that are designed to reinforce and regenerate soft tissues. Soft tissues are defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, nerves and blood vessels. Collagen, the most abundant protein in mammals, is one of the characteristic elements inside the extracellular matrix of soft tissue and, as such, plays a critical role in soft tissue repair. Since soft tissue essentially makes up the majority of a person and there are countless medical conditions associated with soft tissue problems, a select group of large markets related to soft tissue repair will be covered in this report, including breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration.
There are three primary classes of soft tissue repair devices; allografts, xenografts, and alloplasts.
The U.S. soft tissue reinforcement and regeneration market consists of specialized grafting devices utilized for the surgical treatment of a broad range of indications. While synthetic alloplast products have been traditionally used, newer biologic products have been gaining traction in this market. These new products offer superior regenerative results by expediting the healing process and reducing the likelihood of further post-operative complications.
Biologic products have a significantly higher cost, but in most cases, the added benefits they offer outweigh their premium prices. The increasing unit sales of these specialized biologic products combined with their substantially higher ASP will fuel strong growth in the overall market.
The breast reconstruction market will more than double in value over the forecast period. Exceptionally strong double-digit growth will be driven by increases in unit sales volumes. The breast reconstruction market will more than double in value over the forecast period. Exceptionally strong double-digit growth will be driven by increases in unit sales volumes.
The incidence of breast cancer in younger women has been increasing in the United States; this population is more likely to opt for both mastectomy and breast reconstruction. The vast majority of breast reconstructions were tissue expander/implant–based (TEI) reconstructions. The remaining procedures were performed with autologous tissue, using techniques such as latissimus dorsi myocutaneous (LDM) flap, deep inferior epigastric perforators (DIEP) flap and transverse rectus abdominis myocutaneous (TRAM) flap.
In the last few decades, there has been an ongoing trend in the U.S. for women to undergo a prophylactic double mastectomy for preventative measures, even if breast cancer was only diagnosed in one breast. If the patient then decides to undergo breast reconstruction, both breasts must be completely rebuilt. This has caused the rate of bilateral reconstructions to skyrocket and has dramatically impacted the growth of the breast reconstruction market, as one product is usually used for each breast during a reconstructive procedure.
Highlights
There are three primary classes of soft tissue repair devices; allografts, xenografts, and alloplasts.
The U.S. soft tissue reinforcement and regeneration market consists of specialized grafting devices utilized for the surgical treatment of a broad range of indications. While synthetic alloplast products have been traditionally used, newer biologic products have been gaining traction in this market. These new products offer superior regenerative results by expediting the healing process and reducing the likelihood of further post-operative complications.
Biologic products have a significantly higher cost, but in most cases, the added benefits they offer outweigh their premium prices. The increasing unit sales of these specialized biologic products combined with their substantially higher ASP will fuel strong growth in the overall market.
The breast reconstruction market will more than double in value over the forecast period. Exceptionally strong double-digit growth will be driven by increases in unit sales volumes. The breast reconstruction market will more than double in value over the forecast period. Exceptionally strong double-digit growth will be driven by increases in unit sales volumes.
The incidence of breast cancer in younger women has been increasing in the United States; this population is more likely to opt for both mastectomy and breast reconstruction. The vast majority of breast reconstructions were tissue expander/implant–based (TEI) reconstructions. The remaining procedures were performed with autologous tissue, using techniques such as latissimus dorsi myocutaneous (LDM) flap, deep inferior epigastric perforators (DIEP) flap and transverse rectus abdominis myocutaneous (TRAM) flap.
In the last few decades, there has been an ongoing trend in the U.S. for women to undergo a prophylactic double mastectomy for preventative measures, even if breast cancer was only diagnosed in one breast. If the patient then decides to undergo breast reconstruction, both breasts must be completely rebuilt. This has caused the rate of bilateral reconstructions to skyrocket and has dramatically impacted the growth of the breast reconstruction market, as one product is usually used for each breast during a reconstructive procedure.
Highlights
- Analyzes trends between biologic products (allografts and xenografts) and synthetic products
- Covers a broad range of soft tissue related ailments and the graft products used to treat them
- Descriptive and qualitative information for the market drivers and limiters for each chapter
- Section on mergers and acquisitions for 2013 and 2014
- Full competitive analysis of leading competitors
- Discusses the rate of bilateral reconstructions, which is unique in the U.S. compared to other countries
- Discusses differences in growth and price between allografts, xenografts, and alloplasts used for breast reconstructions
- Added sub segments to alloplast segment which include a discussion of difference between growth and price between newer composite alloplasts and the traditional uncoated alloplasts
- Discusses differences in growth and price between biologics and synthetics used for stress urinary incontinence
- Recent changes in reimbursement have and will affect this market
- Compares trends in products used for Achillies tendon reinforcement and rotator cuff reinforcement
- Separated and removed barrier membrane products in order to focus solely on devices that facilitate soft tissue regeneration, resulting in dramatic changes in competitive landscape and amount of growth
EXECUTIVE SUMMARY
1.1 U.S. MARKET FOR SOFT TISSUE REINFORCEMENT AND REGENERATION
1.2 BREAST RECONSTRUCTION MARKET
1.3 HERNIA REPAIR MARKET
1.4 DURAL REPAIR MARKET
1.5 VAGINAL SLING MARKET
1.6 SKIN REPAIR MARKET
1.7 SPORTS MEDICINE AND TENDON REINFORCEMENT MARKET
1.8 DENTAL SOFT TISSUE REGENERATION MARKET
1.9 LEADING COMPETITORS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
U.S. SOFT TISSUE REINFORCEMENT AND REGENERATION MARKET
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.6 HERFINDAHL INDEX
3.7 MERGERS AND ACQUISITIONS
PROCEDURES
4.1 TOTAL PROCEDURES
4.2 BREAST RECONSTRUCTION PROCEDURES
4.3 HERNIA REPAIR PROCEDURES
4.4 DURAL REPAIR PROCEDURES
4.5 VAGINAL SLING PROCEDURES
4.6 SKIN REPAIR PROCEDURES
4.7 SPORTS MEDICINE AND TENDON REINFORCEMENT PROCEDURES
4.8 DENTAL SOFT TISSUE REGENERATION PROCEDURES
BREAST RECONSTRUCTION MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Breast Reconstruction Market
5.3.2 Allograft Market
5.3.3 Xenograft Market
5.3.4 Alloplast Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
HERNIA REPAIR MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Ventral Hernia Repair Market
6.3.1.1 Allograft Market
6.3.1.2 Xenograft Market
6.3.1.3 Total Alloplast Market
6.3.1.3.1 Composite Alloplast Market
6.3.1.3.2 Uncoated Alloplast Market
6.3.2 Total Inguinal Hernia Repair Market
6.3.2.1 Allograft Market
6.3.2.2 Xenograft Market
6.3.2.3 Total Alloplast Market
6.3.2.3.1 Composite Alloplast Market
6.3.2.3.2 Uncoated Alloplast Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS
DURAL REPAIR MARKET
7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total Dural Repair Market
7.3.2 Allograft Market
7.3.3 Xenograft Market
7.3.4 Alloplast Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS
7.5.1 Leading Competitors
VAGINAL SLING MARKET
8.1 INTRODUCTION
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total Vaginal Sling Market
8.3.2 Biologic Market
8.3.3 Synthetic Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS
8.5.1 Leading Competitors
SKIN REPAIR MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Collagen Dressing Market
9.3.2 Skin Substitute Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS
9.5.1 Leading Competitors
SPORTS MEDICINE AND TENDON REINFORCEMENT MARKET
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Rotator Cuff Reinforcement Market
10.3.1.1 Allograft Market
10.3.1.2 Xenograft Market
10.3.1.3 Alloplast Market
10.3.2 Total Achilles Tendon Reinforcement Market
10.3.2.1 Allograft Market
10.3.2.2 Xenograft Market
10.3.2.3 Alloplast Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS
10.5.1 Leading Competitors
DENTAL SOFT TISSUE REGENERATION MARKET
11.1 INTRODUCTION
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 Total Dental Soft Tissue Regeneration Market
11.3.2 Allograft Market
11.3.3 Xenograft Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS
11.5.1 Leading Competitors
ABBREVIATIONS
1.1 U.S. MARKET FOR SOFT TISSUE REINFORCEMENT AND REGENERATION
1.2 BREAST RECONSTRUCTION MARKET
1.3 HERNIA REPAIR MARKET
1.4 DURAL REPAIR MARKET
1.5 VAGINAL SLING MARKET
1.6 SKIN REPAIR MARKET
1.7 SPORTS MEDICINE AND TENDON REINFORCEMENT MARKET
1.8 DENTAL SOFT TISSUE REGENERATION MARKET
1.9 LEADING COMPETITORS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
U.S. SOFT TISSUE REINFORCEMENT AND REGENERATION MARKET
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.6 HERFINDAHL INDEX
3.7 MERGERS AND ACQUISITIONS
PROCEDURES
4.1 TOTAL PROCEDURES
4.2 BREAST RECONSTRUCTION PROCEDURES
4.3 HERNIA REPAIR PROCEDURES
4.4 DURAL REPAIR PROCEDURES
4.5 VAGINAL SLING PROCEDURES
4.6 SKIN REPAIR PROCEDURES
4.7 SPORTS MEDICINE AND TENDON REINFORCEMENT PROCEDURES
4.8 DENTAL SOFT TISSUE REGENERATION PROCEDURES
BREAST RECONSTRUCTION MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Breast Reconstruction Market
5.3.2 Allograft Market
5.3.3 Xenograft Market
5.3.4 Alloplast Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
HERNIA REPAIR MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Ventral Hernia Repair Market
6.3.1.1 Allograft Market
6.3.1.2 Xenograft Market
6.3.1.3 Total Alloplast Market
6.3.1.3.1 Composite Alloplast Market
6.3.1.3.2 Uncoated Alloplast Market
6.3.2 Total Inguinal Hernia Repair Market
6.3.2.1 Allograft Market
6.3.2.2 Xenograft Market
6.3.2.3 Total Alloplast Market
6.3.2.3.1 Composite Alloplast Market
6.3.2.3.2 Uncoated Alloplast Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS
DURAL REPAIR MARKET
7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total Dural Repair Market
7.3.2 Allograft Market
7.3.3 Xenograft Market
7.3.4 Alloplast Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS
7.5.1 Leading Competitors
VAGINAL SLING MARKET
8.1 INTRODUCTION
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total Vaginal Sling Market
8.3.2 Biologic Market
8.3.3 Synthetic Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS
8.5.1 Leading Competitors
SKIN REPAIR MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Collagen Dressing Market
9.3.2 Skin Substitute Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS
9.5.1 Leading Competitors
SPORTS MEDICINE AND TENDON REINFORCEMENT MARKET
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Rotator Cuff Reinforcement Market
10.3.1.1 Allograft Market
10.3.1.2 Xenograft Market
10.3.1.3 Alloplast Market
10.3.2 Total Achilles Tendon Reinforcement Market
10.3.2.1 Allograft Market
10.3.2.2 Xenograft Market
10.3.2.3 Alloplast Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS
10.5.1 Leading Competitors
DENTAL SOFT TISSUE REGENERATION MARKET
11.1 INTRODUCTION
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 Total Dental Soft Tissue Regeneration Market
11.3.2 Allograft Market
11.3.3 Xenograft Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS
11.5.1 Leading Competitors
ABBREVIATIONS
LIST OF CHARTS
Chart 1 1: Soft Tissue Reinforcement and Regeneration Market, U.S., 2011 – 2021
Chart 1 2: Breast Reconstruction ASP by Segment, U.S., 2014 – 2016
Chart 1 3: Ventral Hernia Repair by Segment, U.S., 2013 – 2015
Chart 1 4: Dural Repair Market by Segment, U.S., 2014
Chart 1 5: Unit Sales by Material Type, Vaginal Sling Market, U.S., 2011 – 2014
Chart 1 6: Skin Repair Market Growth by Segment, U.S., 2013 – 2016
Chart 1 7: Sports Medicine and Tendon Reinforcement Market Growth by Segment, U.S., 2014 and 2015
Chart 1 8: Dental Soft Tissue Regeneration Market by Segment, U.S., 2014
Chart 1 9: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Chart 3 1: Soft Tissue Reinforcement and Regeneration Market by Segment, U.S., 2011 – 2021
Chart 3 2: Soft Tissue Reinforcement and Regeneration Market Breakdown, 2014
Chart 3 3: Soft Tissue Reinforcement and Regeneration Market Breakdown, 2021
Chart 3 4: Soft Tissue Reinforcement and Regeneration Market Growth by Segment, U.S., 2011 – 2021
Chart 3 5: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Chart 3 6: Herfindahl Index, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Chart 5 1: Breast Reconstruction Market by Segment, U.S., 2011 – 2021
Chart 5 2: Breast Reconstruction Market Breakdown, U.S., 2014
Chart 5 3: Breast Reconstruction Market Breakdown, U.S., 2021
Chart 5 4: Total Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 5: Allograft Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 6: Xenograft Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 7: Alloplast Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 8: Leading Competitors, Breast Reconstruction Market, U.S., 2014
Chart 6 1: Hernia Repair Market by Segment, U.S., 2011 – 2021
Chart 6 2: Hernia Repair Market Breakdown, U.S., 2014
Chart 6 3: Hernia Repair Market Breakdown, U.S., 2021
Chart 6 4: Total Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 5: Allograft Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 6: Ventral Hernia Repair Xenograft Market, U.S., 2011 – 2021
Chart 6 7: Total Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 8: Composite Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 9: Uncoated Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 10: Total Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 11: Allograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 12: Xenograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 13: Total Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 14: Composite Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 15: Inguinal Hernia Repair Uncoated Alloplast Market, U.S., 2011 – 2021
Chart 6 16: Leading Competitors, Hernia Repair Market, U.S., 2014
Chart 7 1: Dural Repair Market by Segment, U.S., 2011 – 2021
Chart 7 2: Dural Repair Market Breakdown, U.S., 2014
Chart 7 3: Dural Repair Market Breakdown, U.S., 2021
Chart 7 4: Total Dural Repair Market, U.S., 2011 – 2021
Chart 7 5: Allograft Dural Repair Market, U.S., 2011 – 2021
Chart 7 6: Xenograft Dural Repair Market, U.S., 2011 – 2021
Chart 7 7: Alloplast Dural Repair Market, U.S., 2011 – 2021
Chart 7 8: Leading Competitors, Dural Repair Market, U.S., 2014
Chart 8 1: Vaginal Sling Market by Segment, U.S., 2011 – 2021
Chart 8 2: Vaginal Sling Market Breakdown, U.S., 2014
Chart 8 3: Vaginal Sling Market Breakdown, U.S., 2021
Chart 8 4: Total Vaginal Sling Market, U.S., 2011 – 2021
Chart 8 5: Biologic Vaginal Sling Market, U.S., 2011 – 2021
Chart 8 6: Synthetic Vaginal Sling Market, U.S., 2011 – 2021
Chart 8 7: Leading Competitors, Vaginal Sling Market, U.S., 2014
Chart 9 1: Skin Repair Market by Segment, U.S., 2011 – 2021
Chart 9 2: Skin Repair Market Breakdown, U.S., 2014
Chart 9 3: Skin Repair Market Breakdown, U.S., 2021
Chart 9 4: Collagen Dressing Market, U.S., 2011 – 2021
Chart 9 5: Skin Substitute Market, U.S., 2011 – 2021
Chart 9 6: Leading Competitors, Skin Repair Market, U.S., 2014
Chart 10 1: Sports Medicine and Tendon Reinforcement Market by Segment, U.S., 2011 – 2021
Chart 10 2: Sports Medicine and Tendon Reinforcement Market Breakdown, U.S., 2014
Chart 10 3: Sports Medicine and Tendon Reinforcement Market Breakdown, U.S., 2021
Chart 10 4: Total Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 5: Allograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 6: Xenograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 7: Alloplast Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 8: Total Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Chart 10 9: Allograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Chart 10 10: Xenograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Chart 10 11: Achilles Tendon Reinforcement Alloplast Market, U.S., 2011 – 2021
Chart 10 12: Leading Competitors, Sports Medicine and Tendon Reinforcement Market, U.S., 2014
Chart 11 1: Dental Tissue Regeneration Market by Segment, U.S., 2011 – 2021
Chart 11 2: Dental Tissue Regeneration Market Breakdown, U.S., 2014
Chart 11 3: Dental Tissue Regeneration Market Breakdown, U.S., 2021
Chart 11 4: Total Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Chart 11 5: Allograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Chart 11 6: Xenograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Chart 11 7: Leading Competitors, Dental Tissue Regeneration Market, U.S., 2014
Chart 1 1: Soft Tissue Reinforcement and Regeneration Market, U.S., 2011 – 2021
Chart 1 2: Breast Reconstruction ASP by Segment, U.S., 2014 – 2016
Chart 1 3: Ventral Hernia Repair by Segment, U.S., 2013 – 2015
Chart 1 4: Dural Repair Market by Segment, U.S., 2014
Chart 1 5: Unit Sales by Material Type, Vaginal Sling Market, U.S., 2011 – 2014
Chart 1 6: Skin Repair Market Growth by Segment, U.S., 2013 – 2016
Chart 1 7: Sports Medicine and Tendon Reinforcement Market Growth by Segment, U.S., 2014 and 2015
Chart 1 8: Dental Soft Tissue Regeneration Market by Segment, U.S., 2014
Chart 1 9: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Chart 3 1: Soft Tissue Reinforcement and Regeneration Market by Segment, U.S., 2011 – 2021
Chart 3 2: Soft Tissue Reinforcement and Regeneration Market Breakdown, 2014
Chart 3 3: Soft Tissue Reinforcement and Regeneration Market Breakdown, 2021
Chart 3 4: Soft Tissue Reinforcement and Regeneration Market Growth by Segment, U.S., 2011 – 2021
Chart 3 5: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Chart 3 6: Herfindahl Index, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Chart 5 1: Breast Reconstruction Market by Segment, U.S., 2011 – 2021
Chart 5 2: Breast Reconstruction Market Breakdown, U.S., 2014
Chart 5 3: Breast Reconstruction Market Breakdown, U.S., 2021
Chart 5 4: Total Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 5: Allograft Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 6: Xenograft Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 7: Alloplast Breast Reconstruction Market, U.S., 2011 – 2021
Chart 5 8: Leading Competitors, Breast Reconstruction Market, U.S., 2014
Chart 6 1: Hernia Repair Market by Segment, U.S., 2011 – 2021
Chart 6 2: Hernia Repair Market Breakdown, U.S., 2014
Chart 6 3: Hernia Repair Market Breakdown, U.S., 2021
Chart 6 4: Total Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 5: Allograft Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 6: Ventral Hernia Repair Xenograft Market, U.S., 2011 – 2021
Chart 6 7: Total Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 8: Composite Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 9: Uncoated Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Chart 6 10: Total Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 11: Allograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 12: Xenograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 13: Total Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 14: Composite Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Chart 6 15: Inguinal Hernia Repair Uncoated Alloplast Market, U.S., 2011 – 2021
Chart 6 16: Leading Competitors, Hernia Repair Market, U.S., 2014
Chart 7 1: Dural Repair Market by Segment, U.S., 2011 – 2021
Chart 7 2: Dural Repair Market Breakdown, U.S., 2014
Chart 7 3: Dural Repair Market Breakdown, U.S., 2021
Chart 7 4: Total Dural Repair Market, U.S., 2011 – 2021
Chart 7 5: Allograft Dural Repair Market, U.S., 2011 – 2021
Chart 7 6: Xenograft Dural Repair Market, U.S., 2011 – 2021
Chart 7 7: Alloplast Dural Repair Market, U.S., 2011 – 2021
Chart 7 8: Leading Competitors, Dural Repair Market, U.S., 2014
Chart 8 1: Vaginal Sling Market by Segment, U.S., 2011 – 2021
Chart 8 2: Vaginal Sling Market Breakdown, U.S., 2014
Chart 8 3: Vaginal Sling Market Breakdown, U.S., 2021
Chart 8 4: Total Vaginal Sling Market, U.S., 2011 – 2021
Chart 8 5: Biologic Vaginal Sling Market, U.S., 2011 – 2021
Chart 8 6: Synthetic Vaginal Sling Market, U.S., 2011 – 2021
Chart 8 7: Leading Competitors, Vaginal Sling Market, U.S., 2014
Chart 9 1: Skin Repair Market by Segment, U.S., 2011 – 2021
Chart 9 2: Skin Repair Market Breakdown, U.S., 2014
Chart 9 3: Skin Repair Market Breakdown, U.S., 2021
Chart 9 4: Collagen Dressing Market, U.S., 2011 – 2021
Chart 9 5: Skin Substitute Market, U.S., 2011 – 2021
Chart 9 6: Leading Competitors, Skin Repair Market, U.S., 2014
Chart 10 1: Sports Medicine and Tendon Reinforcement Market by Segment, U.S., 2011 – 2021
Chart 10 2: Sports Medicine and Tendon Reinforcement Market Breakdown, U.S., 2014
Chart 10 3: Sports Medicine and Tendon Reinforcement Market Breakdown, U.S., 2021
Chart 10 4: Total Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 5: Allograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 6: Xenograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 7: Alloplast Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Chart 10 8: Total Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Chart 10 9: Allograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Chart 10 10: Xenograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Chart 10 11: Achilles Tendon Reinforcement Alloplast Market, U.S., 2011 – 2021
Chart 10 12: Leading Competitors, Sports Medicine and Tendon Reinforcement Market, U.S., 2014
Chart 11 1: Dental Tissue Regeneration Market by Segment, U.S., 2011 – 2021
Chart 11 2: Dental Tissue Regeneration Market Breakdown, U.S., 2014
Chart 11 3: Dental Tissue Regeneration Market Breakdown, U.S., 2021
Chart 11 4: Total Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Chart 11 5: Allograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Chart 11 6: Xenograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Chart 11 7: Leading Competitors, Dental Tissue Regeneration Market, U.S., 2014
LIST OF FIGURES
Figure 3 1: Soft Tissue Reinforcement and Regeneration Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 3 2: Soft Tissue Reinforcement and Regeneration Market Growth by Segment, U.S., 2011 – 2021
Figure 3 3: Drivers and Limiters, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Figure 3 4: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014 (1 of 2)
Figure 3 5: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014 (2 of 2)
Figure 3 6: Herfindahl Index, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Figure 4 1: Breast Reconstruction Procedures, U.S., 2011 – 2021
Figure 5 1: Breast Reconstruction Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 5 2: Total Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 3: Allograft Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 4: Xenograft Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 5: Alloplast Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 6: Drivers and Limiters, Breast Reconstruction Market, U.S., 2014
Figure 5 7: Leading Competitors, Breast Reconstruction Market, U.S., 2014
Figure 6 1: Hernia Repair Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 6 2: Total Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 3: Allograft Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 4: Ventral Hernia Repair Xenograft Market, U.S., 2011 – 2021
Figure 6 5: Total Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 6: Composite Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 7: Uncoated Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 8: Total Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 9: Allograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 10: Xenograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 11: Total Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 12: Composite Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 13: Inguinal Hernia Repair Uncoated Alloplast Market, U.S., 2011 – 2021
Figure 6 14: Drivers and Limiters, Hernia Repair Market, U.S., 2014
Figure 6 15: Leading Competitors, Hernia Repair Market, U.S., 2014
Figure 7 1: Dural Repair Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 7 2: Total Dural Repair Market, U.S., 2011 – 2021
Figure 7 3: Allograft Dural Repair Market, U.S., 2011 – 2021
Figure 7 4: Xenograft Dural Repair Market, U.S., 2011 – 2021
Figure 7 5: Alloplast Dural Repair Market, U.S., 2011 – 2021
Figure 7 6: Drivers and Limiters, Dural Repair Market, U.S., 2014
Figure 7 7: Leading Competitors, Dural Repair Market, U.S., 2014
Figure 8 1: Vaginal Sling Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 8 2: Total Vaginal Sling Market, U.S., 2011 – 2021
Figure 8 3: Biologic Vaginal Sling Market, U.S., 2011 – 2021
Figure 8 4: Synthetic Vaginal Sling Market, U.S., 2011 – 2021
Figure 8 5: Drivers and Limiters, Vaginal Sling Market, U.S., 2014
Figure 8 6: Leading Competitors, Vaginal Sling Market, U.S., 2014
Figure 9 1: Skin Repair Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 9 2: Collagen Dressing Market, U.S., 2011 – 2021
Figure 9 3: Skin Substitute Market, U.S., 2011 – 2021
Figure 9 4: Drivers and Limiters, Skin Repair Market, U.S., 2014
Figure 9 5: Leading Competitors, Skin Repair Market, U.S., 2014
Figure 10 1: Sports Medicine and Tendon Reinforcement Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 10 2: Total Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 3: Allograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 4: Xenograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 5: Alloplast Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 6: Total Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Figure 10 7: Allograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Figure 10 8: Xenograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Figure 10 9: Achilles Tendon Reinforcement Alloplast Market, U.S., 2011 – 2021
Figure 10 10: Drivers and Limiters, Sports Medicine and Tendon Reinforcement Market, U.S., 2014
Figure 10 11: Leading Competitors, Sports Medicine and Tendon Reinforcement Market, U.S., 2014
Figure 11 1: Dental Tissue Regeneration Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 11 2: Total Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Figure 11 3: Allograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Figure 11 4: Xenograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Figure 11 5: Drivers and Limiters, Dental Tissue Regeneration Market, U.S., 2014
Figure 11 6: Leading Competitors, Dental Tissue Regeneration Market, U.S., 2014
COMPANIES
LifeCell
Organogenesis
C. R. Bard
Ethicon
Covidien
Wright Medical
American Medical Systems
Boston Scientific
Integra LifeSciences
Smith & Nephew
MiMedx
Coloplast
Systagenix
Atrium Medical
BioHorizons
Stryker
Osiris
Cook Medical
Soluble Systems
KCI
Tornier
Synovis/Baxter
Arthrex
Depuy Synthes
RTI Biologics
Biomet
TEI
Geistlich
Zimmer
Acell
Medtronic
Gore Medical
Aesculap/B. Braun
Tiller
Medline
Dentsply
Salvin
Citagenix
Figure 3 1: Soft Tissue Reinforcement and Regeneration Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 3 2: Soft Tissue Reinforcement and Regeneration Market Growth by Segment, U.S., 2011 – 2021
Figure 3 3: Drivers and Limiters, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Figure 3 4: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014 (1 of 2)
Figure 3 5: Leading Competitors, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014 (2 of 2)
Figure 3 6: Herfindahl Index, Soft Tissue Reinforcement and Regeneration Market, U.S., 2014
Figure 4 1: Breast Reconstruction Procedures, U.S., 2011 – 2021
Figure 5 1: Breast Reconstruction Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 5 2: Total Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 3: Allograft Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 4: Xenograft Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 5: Alloplast Breast Reconstruction Market, U.S., 2011 – 2021
Figure 5 6: Drivers and Limiters, Breast Reconstruction Market, U.S., 2014
Figure 5 7: Leading Competitors, Breast Reconstruction Market, U.S., 2014
Figure 6 1: Hernia Repair Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 6 2: Total Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 3: Allograft Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 4: Ventral Hernia Repair Xenograft Market, U.S., 2011 – 2021
Figure 6 5: Total Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 6: Composite Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 7: Uncoated Alloplast Ventral Hernia Repair Market, U.S., 2011 – 2021
Figure 6 8: Total Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 9: Allograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 10: Xenograft Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 11: Total Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 12: Composite Alloplast Inguinal Hernia Repair Market, U.S., 2011 – 2021
Figure 6 13: Inguinal Hernia Repair Uncoated Alloplast Market, U.S., 2011 – 2021
Figure 6 14: Drivers and Limiters, Hernia Repair Market, U.S., 2014
Figure 6 15: Leading Competitors, Hernia Repair Market, U.S., 2014
Figure 7 1: Dural Repair Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 7 2: Total Dural Repair Market, U.S., 2011 – 2021
Figure 7 3: Allograft Dural Repair Market, U.S., 2011 – 2021
Figure 7 4: Xenograft Dural Repair Market, U.S., 2011 – 2021
Figure 7 5: Alloplast Dural Repair Market, U.S., 2011 – 2021
Figure 7 6: Drivers and Limiters, Dural Repair Market, U.S., 2014
Figure 7 7: Leading Competitors, Dural Repair Market, U.S., 2014
Figure 8 1: Vaginal Sling Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 8 2: Total Vaginal Sling Market, U.S., 2011 – 2021
Figure 8 3: Biologic Vaginal Sling Market, U.S., 2011 – 2021
Figure 8 4: Synthetic Vaginal Sling Market, U.S., 2011 – 2021
Figure 8 5: Drivers and Limiters, Vaginal Sling Market, U.S., 2014
Figure 8 6: Leading Competitors, Vaginal Sling Market, U.S., 2014
Figure 9 1: Skin Repair Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 9 2: Collagen Dressing Market, U.S., 2011 – 2021
Figure 9 3: Skin Substitute Market, U.S., 2011 – 2021
Figure 9 4: Drivers and Limiters, Skin Repair Market, U.S., 2014
Figure 9 5: Leading Competitors, Skin Repair Market, U.S., 2014
Figure 10 1: Sports Medicine and Tendon Reinforcement Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 10 2: Total Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 3: Allograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 4: Xenograft Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 5: Alloplast Rotator Cuff Reinforcement Market, U.S., 2011 – 2021
Figure 10 6: Total Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Figure 10 7: Allograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Figure 10 8: Xenograft Achilles Tendon Reinforcement Market, U.S., 2011 – 2021
Figure 10 9: Achilles Tendon Reinforcement Alloplast Market, U.S., 2011 – 2021
Figure 10 10: Drivers and Limiters, Sports Medicine and Tendon Reinforcement Market, U.S., 2014
Figure 10 11: Leading Competitors, Sports Medicine and Tendon Reinforcement Market, U.S., 2014
Figure 11 1: Dental Tissue Regeneration Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 11 2: Total Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Figure 11 3: Allograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Figure 11 4: Xenograft Dental Soft Tissue Regeneration Market, U.S., 2011 – 2021
Figure 11 5: Drivers and Limiters, Dental Tissue Regeneration Market, U.S., 2014
Figure 11 6: Leading Competitors, Dental Tissue Regeneration Market, U.S., 2014
COMPANIES
LifeCell
Organogenesis
C. R. Bard
Ethicon
Covidien
Wright Medical
American Medical Systems
Boston Scientific
Integra LifeSciences
Smith & Nephew
MiMedx
Coloplast
Systagenix
Atrium Medical
BioHorizons
Stryker
Osiris
Cook Medical
Soluble Systems
KCI
Tornier
Synovis/Baxter
Arthrex
Depuy Synthes
RTI Biologics
Biomet
TEI
Geistlich
Zimmer
Acell
Medtronic
Gore Medical
Aesculap/B. Braun
Tiller
Medline
Dentsply
Salvin
Citagenix
